Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
C. Wang, K. Kaur, C. Xu…·G. Mbalaviele
This study shows doxorubicin causes bone loss via inflammasome activation, leading to pyroptosis and NETosis, and identifies AIM2 and NLRP3 as key mediators.